Cytosorbents Corp

CTSO Nasdaq CIK: 0001175151

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Mailing Address 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Phone 973-329-8885
Fiscal Year End 1231
EIN 980373793

Financial Overview

FY2025

$11.11M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 30, 2026 View on SEC
8-K Current report of material events March 25, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
4 Insider stock transaction report November 20, 2025 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
10-Q Quarterly financial report November 13, 2025 View on SEC
8-K Current report of material events October 3, 2025 View on SEC
8-K Current report of material events September 16, 2025 View on SEC
8-K Current report of material events August 20, 2025 View on SEC
4 Insider stock transaction report August 8, 2025 View on SEC

Annual Reports

10-K March 30, 2026
  • Developing DrugSorb-ATR to eliminate pre-surgery wait times for patients on blood thinners.
  • Significant reduction in annual losses from $20.7 million in 2023 to $8.2 million in 2024.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.